Modified Cervical Inversion During CS in Placenta Previa

NCT ID: NCT03772184

Last Updated: 2022-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-10

Study Completion Date

2019-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is an increasing rates of placenta previa nowadays

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

several techniques were described to control bleeding .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Placenta Previa

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Using cervical inversion during cesarean section
Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cervical inversion

Group Type ACTIVE_COMPARATOR

Cervical inversion

Intervention Type PROCEDURE

inverting the cervical lip after delivery

no cervical inversion

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cervical inversion

inverting the cervical lip after delivery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pregnant women 38 weeks or more with placenta previa

Exclusion Criteria

* pregnant ladies with normally implanted placenta or placenta accreat , increta or percreta
Minimum Eligible Age

22 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Suez Canal University

OTHER

Sponsor Role collaborator

Aljazeera Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mahmoud Alalfy

Lecturer Obstetrics and Gyneology , National Research Centre

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mahmoud Alalfy, PhD

Role: PRINCIPAL_INVESTIGATOR

National research centre , Aljazeerah hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Algazeerah and helwan university

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Modified cervical inversion

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Amnioreduction in Polyhydramnios
NCT07067593 NOT_YET_RECRUITING